Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06973785 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Non-Narcotic Pain Control After ACL Reconstruction

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: Phase 3 → Phase 2
    • Eligibility criteria expanded, about 28 words
    v4
  2. Trial status: Recruiting to Active, Not Recruitingv3 Show 4 more changesShow less
    • Primary completion date changed from estimate of Sep 30, 2026 to Jun 12, 2026
    • Study completion date: Dec 31, 2026 to Jun 15, 2027
    • Site details revised at 3 of 3 sites
    • Study description expanded, about 4 words
  3. Primary completion date: Dec 31, 2025 to Sep 30, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Start date changed from estimate of May 15, 2025 to Jul 15, 2025
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a double-blind randomized controlled trial of standard of care therapy, either oral ketorolac (experimental group) or oral oxycodone (control group) to demonstrate efficacy in reducing the percentage of narcotic doses taken and documenting the number of patients with no exposure to any narcotics (take zero oxycodone) after undergoing primary knee ACL reconstruction outpatient surgery.
Trial Details
NCT Number NCT06973785
Lead Sponsor The Cleveland Clinic
Conditions
(from sponsor)		 ACL - Anterior Cruciate Ligament Rupture, ACL Injuries
Related terms Anterior Cruciate Ligament Injuries
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov